Igor G. Spiridonov
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Igor G. Spiridonov has a total of 68 co-authors. Here are the top co-authors by number of shared publications:
- Elena V. Ushakova
Department of Materials Science and Engineering City University of Hong Kong Hong Kong China
4 shared publications - Evgeniy V. Zhizhin
Research Park, Saint Petersburg State University, Saint Petersburg 199034, Russia
4 shared publications - Mikhail D. Miruschenko
International Research and Education Center for Physics of Nanostructures ITMO University Saint Petersburg Russia
4 shared publications - Andrey L. Rogach
City University of Hong Kong
3 shared publications Aleksandra V. Koroleva
Research Park, Saint Petersburg State University, Saint Petersburg 199034, Russia
2 shared publications- Aleksandra V. Koroleva
Institute of Earth Sciences, Saint Petersburg State University, University Emb. 7/9, St. Petersburg 199034, Russia
2 shared publications
Latest Publications
- Open Access
- 9 February 2024
- Published by Royal Society of Chemistry (RSC) in Journal of Materials Chemistry C
- Vol. 12 (11) , 3943-3952
Amphiphilic acetylacetone-based carbon dots
On-going development of carbon dots (CDs) for different applications calls for search of novel methods for their synthesis and surface functionalization. For fabrication of photonic devices, CDs should be soluble in non-polar solvents that are used for ink-printing of their functional layers, apart from the obvious requirement of bright luminescence. Herein, we introduce amphiphilic CDs synthesized from a mixture of benzoic acid and ethylenediamine in acetylacetone, which satisfy both above mentioned requirements. These CDs are quasi-spherical nanoparticles 20-50 nm in size, holding aliphatic, carbonyl, amide, imine, and carbamate groups at the surface which renders them amphiphilic and soluble in a variety of substances with relative polarity ranging from 0.002 to 1, such as toluene, chloroform, alcohols, and water. By variation of the molar ratio of benzoic acid and ethylenediamine, a highest quantum yield of 36 % in isopropanol is achieved for the amphiphilic CDs reported so far. As a demonstration of use of developed amphiphilic CDs in LEDs, green emitting charge-injection devices were fabricated with a broad emission band centered at 515 nm, maximal luminance of 1716 cd/m2, and ССT of 5627 K which is the first LED based on amphiphilic CDs. Furthermore, these CDs can be used as luminescent inks, and as active material for solar concentrators.
- 9 February 2024
- Published by Royal Society of Chemistry (RSC) in Journal of Materials Chemistry C
- Vol. 12 (11) , 3943-3952
Open AccessAmphiphilic acetylacetone-based carbon dots
On-going development of carbon dots (CDs) for different applications calls for search of novel methods for their synthesis and surface functionalization. For fabrication of photonic devices, CDs should be soluble in non-polar solvents that are used for ink-printing of their functional layers, apart from the obvious requirement of bright luminescence. Herein, we introduce amphiphilic CDs synthesized from a mixture of benzoic acid and ethylenediamine in acetylacetone, which satisfy both above mentioned requirements. These CDs are quasi-spherical nanoparticles 20-50 nm in size, holding aliphatic, carbonyl, amide, imine, and carbamate groups at the surface which renders them amphiphilic and soluble in a variety of substances with relative polarity ranging from 0.002 to 1, such as toluene, chloroform, alcohols, and water. By variation of the molar ratio of benzoic acid and ethylenediamine, a highest quantum yield of 36 % in isopropanol is achieved for the amphiphilic CDs reported so far. As a demonstration of use of developed amphiphilic CDs in LEDs, green emitting charge-injection devices were fabricated with a broad emission band centered at 515 nm, maximal luminance of 1716 cd/m2, and ССT of 5627 K which is the first LED based on amphiphilic CDs. Furthermore, these CDs can be used as luminescent inks, and as active material for solar concentrators.
- Open Access
- 4 August 2023
- Published by American Chemical Society (ACS) in ChemRxiv
Amphiphilic Acetylacetone-Based Carbon Dots
On-going development of carbon dots (CDs) for different applications calls for search of novel methods for their synthesis and surface functionalization. For fabrication of light-emitting devices (LEDs), CDs should be soluble in non-polar solvents that are used for ink-printing of their functional layers, apart from the obvious requirement of bright luminescence. Herein, we introduce amphiphilic CDs synthesized from a mixture of benzoic acid and ethylenediamine in acetylacetone, which satisfy both above mentioned requirements. These CDs are quasi-spherical nanoparticles 20-50 nm in size, holding aliphatic, carbonyl, amide, imine, and carbamate groups at the surface which renders them amphiphilic and soluble in a variety of substances with relative polarity ranging from 0.002 to 1, such as toluene, chloroform, alcohols, and water. By variation of the molar ratio of benzoic acid and ethylenediamine, an optimal value for photoluminescence quantum yield of 36 % in non-polar solvents is achieved. Importantly, these CDs are easily mixable with a charge transport polymer – polyvinylcarbazole, a common component of organic LEDs. As a demonstration of use of developed amphiphilic CDs in LEDs, green emitting charge-injection devices are fabricated with a broad emission band centered at 515 nm, maximal luminance of 1716 cd/m2, and ССT of 5627 K.
- 4 August 2023
- Published by American Chemical Society (ACS) in ChemRxiv
Open AccessAmphiphilic Acetylacetone-Based Carbon Dots
On-going development of carbon dots (CDs) for different applications calls for search of novel methods for their synthesis and surface functionalization. For fabrication of light-emitting devices (LEDs), CDs should be soluble in non-polar solvents that are used for ink-printing of their functional layers, apart from the obvious requirement of bright luminescence. Herein, we introduce amphiphilic CDs synthesized from a mixture of benzoic acid and ethylenediamine in acetylacetone, which satisfy both above mentioned requirements. These CDs are quasi-spherical nanoparticles 20-50 nm in size, holding aliphatic, carbonyl, amide, imine, and carbamate groups at the surface which renders them amphiphilic and soluble in a variety of substances with relative polarity ranging from 0.002 to 1, such as toluene, chloroform, alcohols, and water. By variation of the molar ratio of benzoic acid and ethylenediamine, an optimal value for photoluminescence quantum yield of 36 % in non-polar solvents is achieved. Importantly, these CDs are easily mixable with a charge transport polymer – polyvinylcarbazole, a common component of organic LEDs. As a demonstration of use of developed amphiphilic CDs in LEDs, green emitting charge-injection devices are fabricated with a broad emission band centered at 515 nm, maximal luminance of 1716 cd/m2, and ССT of 5627 K.
- 17 April 2023
- Published by Royal Society of Chemistry (RSC) in Nanoscale
- Vol. 15 (19) , 8845-8853
Energy-level engineering of carbon dots through a post-synthetic treatment with acids and amines
Chemically synthesized carbon dots (CDs) have attracted a lot of attention as an eco-friendly and cost-efficient light-emitting material, and functionalization of CD surfaces with additives of different natures is a useful way to control their properties. In this study, we show how a post-synthetic treatment of CDs with citric acid, benzoic acid, urea and o-phenylenediamine changes their chemical composition and optical properties. In particular, it results in the formation of carboxyl/imide/carbonyl groups at the CD surface, leading to the appearance of additional blue (or for CDs treated with phenylenediamine, blue and green) emissive optical centers on top of the remaining emission from the original CDs. Most importantly, the increased oxidation degree alongside a decreased relative amount of carbon and nitrogen in such treated CDs decreases their highest occupied molecular orbital (HOMO) energy level by up to 0.9 eV (the maximal value was observed for CDs treated with o-phenylenediamine). Moreover, the Fermi energy level shifted above the lowest unoccupied molecular orbital (LUMO) energy level for some of the treated CD samples. Thus, the energy structure of CDs can be tuned and optimized for further applications through the functionalization of their surface with organic additives.
- 17 April 2023
- Published by Royal Society of Chemistry (RSC) in Nanoscale
- Vol. 15 (19) , 8845-8853
Energy-level engineering of carbon dots through a post-synthetic treatment with acids and amines
Chemically synthesized carbon dots (CDs) have attracted a lot of attention as an eco-friendly and cost-efficient light-emitting material, and functionalization of CD surfaces with additives of different natures is a useful way to control their properties. In this study, we show how a post-synthetic treatment of CDs with citric acid, benzoic acid, urea and o-phenylenediamine changes their chemical composition and optical properties. In particular, it results in the formation of carboxyl/imide/carbonyl groups at the CD surface, leading to the appearance of additional blue (or for CDs treated with phenylenediamine, blue and green) emissive optical centers on top of the remaining emission from the original CDs. Most importantly, the increased oxidation degree alongside a decreased relative amount of carbon and nitrogen in such treated CDs decreases their highest occupied molecular orbital (HOMO) energy level by up to 0.9 eV (the maximal value was observed for CDs treated with o-phenylenediamine). Moreover, the Fermi energy level shifted above the lowest unoccupied molecular orbital (LUMO) energy level for some of the treated CD samples. Thus, the energy structure of CDs can be tuned and optimized for further applications through the functionalization of their surface with organic additives.
- Open Access
- 23 September 2022
- Published by MDPI AG in Nanomaterials
- Vol. 12 (19) , 3314
Dual-Purpose Sensing Nanoprobe Based on Carbon Dots from o-Phenylenediamine: pH and Solvent Polarity Measurement
Today, the development of nanomaterials with sensing properties attracts much scientific interest because of the demand for low-cost nontoxic colloidal nanoprobes with high sensitivity and selectivity for various biomedical and environment-related applications. Carbon dots (CDs) are promising candidates for these applications as they demonstrate unique optical properties with intense emissions, biocompatibility, and ease of fabrication. Herein, we developed synthesis protocols to obtain CDs based on o-phenylenediamine with a variety of optical responses depending on additional precursors and changes in the reaction media. The obtained CDs are N-doped (N,S-doped in case of thiourea addition) less than 10 nm spherical particles with emissions observed in the 300–600 nm spectral region depending on their chemical composition. These CDs may act simultaneously as absorptive/fluorescent sensing probes for solvent polarity with up to 85, for from 0.099 to 1.0 and for pH values in the range of 3.0–8.0, thus opening an opportunity to check the pH in non-pure water or a mixture of solvents. Moreover, CDs preserve their optical properties when embedded in cellulose strips that can be used as sensing probes for fast and easy pH checks. We believe that the resulting dual-purpose sensing nano probes based on CDs will have high demand in various sensing applications.- 23 September 2022
- Published by MDPI AG in Nanomaterials
- Vol. 12 (19) , 3314
Open AccessDual-Purpose Sensing Nanoprobe Based on Carbon Dots from o-Phenylenediamine: pH and Solvent Polarity Measurement
Today, the development of nanomaterials with sensing properties attracts much scientific interest because of the demand for low-cost nontoxic colloidal nanoprobes with high sensitivity and selectivity for various biomedical and environment-related applications. Carbon dots (CDs) are promising candidates for these applications as they demonstrate unique optical properties with intense emissions, biocompatibility, and ease of fabrication. Herein, we developed synthesis protocols to obtain CDs based on o-phenylenediamine with a variety of optical responses depending on additional precursors and changes in the reaction media. The obtained CDs are N-doped (N,S-doped in case of thiourea addition) less than 10 nm spherical particles with emissions observed in the 300–600 nm spectral region depending on their chemical composition. These CDs may act simultaneously as absorptive/fluorescent sensing probes for solvent polarity with up to 85, for from 0.099 to 1.0 and for pH values in the range of 3.0–8.0, thus opening an opportunity to check the pH in non-pure water or a mixture of solvents. Moreover, CDs preserve their optical properties when embedded in cellulose strips that can be used as sensing probes for fast and easy pH checks. We believe that the resulting dual-purpose sensing nano probes based on CDs will have high demand in various sensing applications. - Open Access
- 15 December 2021
- Published by ECO-Vector LLC in Journal of Clinical Practice
- Vol. 12 (4) , 23-37
The use of the thrombodynamics test in the diagnostics of hemostasis disorders in patients with COVID-19 of varying severity
Background: At the present moment, an urgent and unresolved problem is the search for a method to diagnose disorders of the hemostasis system in patients with the new coronavirus infection. The integral tests, in particular, the thrombodynamics test, will presumably make it possible to monitor changes in blood clotting, and predict the course of the disease in patients with COVID-19. Aims: To comparatively assess the plasma hemostasis parameters and results of the thrombodynamics test in patients with COVID-19 viral infection of different severity. Methods: The study included 96 patients with a confirmed diagnosis of COVID-19, admitted to a hospital for infectious diseases on the base of the V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology, and Perinatology in the period from April 23, 2020, to June 20, 2020, and discharged at the end of treatment. SARS-CoV-2 was identified by PCR. The patients were stratified by the severity into 3 groups: mild course (n=25), moderate course (n=54), severe course (n=17). The diagnostics and treatment of patients were carried out in accordance with the Temporary Methodological Recommendations of the Ministry of Health of the Russian Federation for the prevention, diagnosis and treatment of the new coronavirus infection, versions 5, 6, 7. In the course of the treatment, the patients were assessed for APTT, prothrombin %, prothrombin time (PT) and thrombin time, fibrinogen, D-dimer, platelet count, and the thrombodynamic test parameters (V/Vi/Vst, Tlag, Cs, D). Results: Significant differences were observed in the thrombin time, D-dimer, platelet count, and the thrombodynamic parameters of V/Vst, Cs, and D taken before admission and a week after admission. We found a relationship between the parameters of hemostasis (fibrinogen concentration, PT, prothrombin %, APTT, Tlag, D) and the duration of hospital stay. There was a positive relationship between the content of fibrinogen and D (r=0.6307, p 0.0001) and a strong positive relationship between PT and Tlag (r=0.7499, p 0.0001). Conclusions: The thrombodynamics test can be recommended as a potential tool for a personalized approach to monitoring the hemostasis system and treating patients with COVID-19.
- 15 December 2021
- Published by ECO-Vector LLC in Journal of Clinical Practice
- Vol. 12 (4) , 23-37
Open AccessThe use of the thrombodynamics test in the diagnostics of hemostasis disorders in patients with COVID-19 of varying severity
Background: At the present moment, an urgent and unresolved problem is the search for a method to diagnose disorders of the hemostasis system in patients with the new coronavirus infection. The integral tests, in particular, the thrombodynamics test, will presumably make it possible to monitor changes in blood clotting, and predict the course of the disease in patients with COVID-19. Aims: To comparatively assess the plasma hemostasis parameters and results of the thrombodynamics test in patients with COVID-19 viral infection of different severity. Methods: The study included 96 patients with a confirmed diagnosis of COVID-19, admitted to a hospital for infectious diseases on the base of the V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology, and Perinatology in the period from April 23, 2020, to June 20, 2020, and discharged at the end of treatment. SARS-CoV-2 was identified by PCR. The patients were stratified by the severity into 3 groups: mild course (n=25), moderate course (n=54), severe course (n=17). The diagnostics and treatment of patients were carried out in accordance with the Temporary Methodological Recommendations of the Ministry of Health of the Russian Federation for the prevention, diagnosis and treatment of the new coronavirus infection, versions 5, 6, 7. In the course of the treatment, the patients were assessed for APTT, prothrombin %, prothrombin time (PT) and thrombin time, fibrinogen, D-dimer, platelet count, and the thrombodynamic test parameters (V/Vi/Vst, Tlag, Cs, D). Results: Significant differences were observed in the thrombin time, D-dimer, platelet count, and the thrombodynamic parameters of V/Vst, Cs, and D taken before admission and a week after admission. We found a relationship between the parameters of hemostasis (fibrinogen concentration, PT, prothrombin %, APTT, Tlag, D) and the duration of hospital stay. There was a positive relationship between the content of fibrinogen and D (r=0.6307, p 0.0001) and a strong positive relationship between PT and Tlag (r=0.7499, p 0.0001). Conclusions: The thrombodynamics test can be recommended as a potential tool for a personalized approach to monitoring the hemostasis system and treating patients with COVID-19.
- 14 December 2020
- Published by Pediatria, Ltd. in Pediatria. Journal named after G.N. Speransky
- Vol. 99 (6)
RESULTS OF MULTICENTER MONITORING OF HEMOSTASIS PARAMETERS IN PATIENTS WITH COVID-19
Materials and methods: a prospective non-randomized pilot multicenter study of the informativeness and clinical significance of hemostasis laboratory tests in 1210 patients with COVID-19 in disease course, including favorable and unfavorable outcomes, was performed. Hemostasis was assessed using clotting tests and D-dimer concentration, thromboelastography (TEG) and thrombodynamics (TD). Results: comparison of COVID-19 laboratory parameters and clinical picture showed that 75% of patients have pronounced activation of the plasma coagulation system upon admission to the hospital. Hypercoagulation is recorded in all tests, reaching a maximum in patients with subtotal (CT-3) and total (CT-4) lung lesion and/or resuscitation patients with a clinical picture of pulmonary embolism and unfavorable outcome. Low molecular weight heparins (LMWH) in a standard dosage leads to suppression of the initial hypercoagulable syndrome in more than half of the patients (from 75 to 31%). All patients without LMWH laboratory effect developed thrombotic complications. For clotting tests, insufficient sensitivity to changes in hemostasis against the background of LMWH was revealed. The D-dimer test effectively correlates with the severity and outcomes of COVID-19, but is not suitable for the control of heparin therapy, which is associated with the effect of lysis of existing blood clots and the lack of response to a decrease in the coagulation activity of patients. Methods of thromboelastography and thrombodynamics effectively record a decrease in the activity of the coagulation system and can be used to control heparin therapy. The correlation coefficient between the methods was 0,77. The dynamic indices of D-dimers, TEG and TD in severe patients and, especially, in patients with fatal outcomes revealed the greatest sensitivity to the control of heparin therapy in the Thrombodynamics test, which allows, along with thrombosis, to record hypercoagulable states and the risk of bleeding, which are the outcome of thrombohemorrhagic syndrome in patients with COVID-19.
- 14 December 2020
- Published by Pediatria, Ltd. in Pediatria. Journal named after G.N. Speransky
- Vol. 99 (6)
RESULTS OF MULTICENTER MONITORING OF HEMOSTASIS PARAMETERS IN PATIENTS WITH COVID-19
Materials and methods: a prospective non-randomized pilot multicenter study of the informativeness and clinical significance of hemostasis laboratory tests in 1210 patients with COVID-19 in disease course, including favorable and unfavorable outcomes, was performed. Hemostasis was assessed using clotting tests and D-dimer concentration, thromboelastography (TEG) and thrombodynamics (TD). Results: comparison of COVID-19 laboratory parameters and clinical picture showed that 75% of patients have pronounced activation of the plasma coagulation system upon admission to the hospital. Hypercoagulation is recorded in all tests, reaching a maximum in patients with subtotal (CT-3) and total (CT-4) lung lesion and/or resuscitation patients with a clinical picture of pulmonary embolism and unfavorable outcome. Low molecular weight heparins (LMWH) in a standard dosage leads to suppression of the initial hypercoagulable syndrome in more than half of the patients (from 75 to 31%). All patients without LMWH laboratory effect developed thrombotic complications. For clotting tests, insufficient sensitivity to changes in hemostasis against the background of LMWH was revealed. The D-dimer test effectively correlates with the severity and outcomes of COVID-19, but is not suitable for the control of heparin therapy, which is associated with the effect of lysis of existing blood clots and the lack of response to a decrease in the coagulation activity of patients. Methods of thromboelastography and thrombodynamics effectively record a decrease in the activity of the coagulation system and can be used to control heparin therapy. The correlation coefficient between the methods was 0,77. The dynamic indices of D-dimers, TEG and TD in severe patients and, especially, in patients with fatal outcomes revealed the greatest sensitivity to the control of heparin therapy in the Thrombodynamics test, which allows, along with thrombosis, to record hypercoagulable states and the risk of bleeding, which are the outcome of thrombohemorrhagic syndrome in patients with COVID-19.